Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-CarboxamidesPer Björk, Tomas Leanderson, Anders Björk et al.|PLoS Biology|2009Cited by 358
S100A9 Interaction with TLR4 Promotes Tumor GrowthEva Källberg, Tomas Leanderson, Thomas Vogl et al.|PLoS ONE|2012Cited by 138
Induction of nuclear factor‐κ<scp>B</scp> responses by the <scp>S</scp>100<scp>A</scp>9 protein is Toll‐like receptor‐4‐dependentMatteo Riva, Tomas Leanderson, Eva Källberg et al.|Immunology|2012Cited by 133
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer MicroenvironmentJohn T. Isaacs, Tomas Leanderson, Lizamma Antony et al.|Cancer Research|2012Cited by 113